May 2 (Reuters) - Anglo-Swedish drugmaker AstraZeneca ( AZN )
on Friday said its inhaler therapy Breztri Aerosphere
met all the main goals of two late-stage trials in patients with
uncontrolled asthma.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Mrigank
Dhaniwala)